Biden administration to allow new injection method for monkeypox vaccine

The Biden administration has decided to stretch out its limited supply of monkeypox vaccine by allowing a different method of injection that uses one-fifth as much per shot, the New York Times reported on Monday, citing senior officials familiar with the planning.
The United States declared monkeypox a public health emergency last week, in an effort to bolster the U.S. response to contain the outbreak.
For U.S. Food and Drug Administration (FDA) to authorize the intradermal injection, which requires injecting one-fifth of the current dose into the skin instead of a full dose into underlying fat, the Department of Health and Human Services (HHS) will need to issue a new emergency declaration, the report said, allowing regulators to invoke the FDA’s emergency use powers.
The announcement is expected as early as Tuesday afternoon, according to the newspaper.